169 related articles for article (PubMed ID: 32936585)
1. Pharmacological Treatment for Comorbid Bipolar Disorder and Obsessive-Compulsive Disorder in Adults.
Netto VM; Flores CA; Pallanti S
J Psychiatr Pract; 2020 Sep; 26(5):383-393. PubMed ID: 32936585
[TBL] [Abstract][Full Text] [Related]
2. Aripiprazole augmentation in treating comorbid bipolar disorder and obsessive-compulsive disorder: A systematic review.
Amerio A; Odone A; Ghaemi SN
J Affect Disord; 2019 Apr; 249():15-19. PubMed ID: 30743017
[TBL] [Abstract][Full Text] [Related]
3. Treatment of comorbid bipolar disorder and obsessive-compulsive disorder: a systematic review.
Amerio A; Odone A; Marchesi C; Ghaemi SN
J Affect Disord; 2014 Sep; 166():258-63. PubMed ID: 25012439
[TBL] [Abstract][Full Text] [Related]
4. Updates in treating comorbid bipolar disorder and obsessive-compulsive disorder: A systematic review.
Amerio A; Maina G; Ghaemi SN
J Affect Disord; 2019 Sep; 256():433-440. PubMed ID: 31234022
[TBL] [Abstract][Full Text] [Related]
5. Bipolar co-morbidity in pediatric obsessive-compulsive disorder: clinical and treatment implications.
Masi G; Perugi G; Millepiedi S; Toni C; Mucci M; Pfanner C; Berloffa S; Pari C; Akiskal HS
J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):475-86. PubMed ID: 17822342
[TBL] [Abstract][Full Text] [Related]
6. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
Bloch MH; Landeros-Weisenberger A; Kelmendi B; Coric V; Bracken MB; Leckman JF
Mol Psychiatry; 2006 Jul; 11(7):622-32. PubMed ID: 16585942
[TBL] [Abstract][Full Text] [Related]
7. Topiramate as an adjuvant treatment for obsessive compulsive symptoms in patients with bipolar disorder: a randomized double blind placebo controlled clinical trial.
Sahraian A; Bigdeli M; Ghanizadeh A; Akhondzadeh S
J Affect Disord; 2014 Sep; 166():201-5. PubMed ID: 25012432
[TBL] [Abstract][Full Text] [Related]
8. Aripiprazole Augmentation to Mood Stabilizers for Obsessive-Compulsive Symptoms in Bipolar Disorder.
Di Salvo G; Maina G; Pessina E; Teobaldi E; Barbaro F; Martini A; Albert U; Rosso G
Medicina (Kaunas); 2020 Dec; 57(1):. PubMed ID: 33374357
[No Abstract] [Full Text] [Related]
9. Impact of obsessive-compulsive disorder on the antimanic response to olanzapine therapy in youth with bipolar disorder.
Joshi G; Mick E; Wozniak J; Geller D; Park J; Strauss S; Biederman J
Bipolar Disord; 2010 Mar; 12(2):196-204. PubMed ID: 20402712
[TBL] [Abstract][Full Text] [Related]
10. Obsessive-compulsive-bipolar comorbidity: a systematic exploration of clinical features and treatment outcome.
Perugi G; Toni C; Frare F; Travierso MC; Hantouche E; Akiskal HS
J Clin Psychiatry; 2002 Dec; 63(12):1129-34. PubMed ID: 12523872
[TBL] [Abstract][Full Text] [Related]
11. Treatment of the obsessive-compulsive and bipolar disorders comorbidity: pharmacodynamic and pharmacokinetic evaluation.
Marazziti D; Mucci F; Avella MT; Dell'Oste V; Baroni S; Dell'Osso L
Expert Opin Drug Metab Toxicol; 2019 Aug; 15(8):619-631. PubMed ID: 31271537
[No Abstract] [Full Text] [Related]
12. Clinical management of comorbid bipolar disorder and obsessive-compulsive disorder: A case series.
Amerio A; Tonna M; Odone A
Acta Biomed; 2018 Nov; 89(4):581-584. PubMed ID: 30657129
[TBL] [Abstract][Full Text] [Related]
13. Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?
Geller DA; Biederman J; Stewart SE; Mullin B; Farrell C; Wagner KD; Emslie G; Carpenter D
J Child Adolesc Psychopharmacol; 2003; 13 Suppl 1():S19-29. PubMed ID: 12880497
[TBL] [Abstract][Full Text] [Related]
14. Memantine as an Adjuvant Treatment for Obsessive Compulsive Symptoms in Manic Phase of Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Sahraian A; Jahromi LR; Ghanizadeh A; Mowla A
J Clin Psychopharmacol; 2017 Apr; 37(2):246-249. PubMed ID: 28099183
[TBL] [Abstract][Full Text] [Related]
15. Management of obsessive-compulsive disorder comorbid with bipolar disorder.
Kazhungil F; Mohandas E
Indian J Psychiatry; 2016; 58(3):259-269. PubMed ID: 28066002
[TBL] [Abstract][Full Text] [Related]
16. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis.
Issari Y; Jakubovski E; Bartley CA; Pittenger C; Bloch MH
J Clin Psychiatry; 2016 May; 77(5):e605-11. PubMed ID: 27249090
[TBL] [Abstract][Full Text] [Related]
17. The prevalence and predictors of comorbid bipolar disorder and obsessive-compulsive disorder: A systematic review and meta-analysis.
Amerio A; Stubbs B; Odone A; Tonna M; Marchesi C; Ghaemi SN
J Affect Disord; 2015 Nov; 186():99-109. PubMed ID: 26233320
[TBL] [Abstract][Full Text] [Related]
18. Clinical and familial profile of bipolar disorder with and without obsessive-compulsive disorder: an Indian study.
Kazhungil F; Cholakottil A; Kattukulathil S; Kottelassal A; Vazhakalayil R
Trends Psychiatry Psychother; 2017; 39(4):270-275. PubMed ID: 29267510
[TBL] [Abstract][Full Text] [Related]
19. [Treatment-resistant anxiety disorders: A literature review of drug therapy strategies].
Ammar G; Naja WJ; Pelissolo A
Encephale; 2015 Jun; 41(3):260-5. PubMed ID: 25439852
[TBL] [Abstract][Full Text] [Related]
20. Glutamatergic Agents as Add-On Medication for the Treatment of Obsessive-Compulsive Disorder: A Systematic Review and Meta-Analysis.
Laoutidis ZG; Lekka GE; Kioulos KT
J Clin Psychiatry; 2016 Dec; 77(12):e1576-e1583. PubMed ID: 27780337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
